ARCHIVES

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

This article is from The Cancer Letter archive.

Vol. 20 No. 33 | August 19, 1994

Download PDF Visit The Full Archive

Related Articles

Power’s Offer to Write Report On NCAB’s Organ Systems Decision Declined By DeVita

June 15, 1984

UPCI Opens New Facility; Gomella Wins NCI Award.

July 4, 2003

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

White House Okays Committee ‘Kill’ Lists; Workshops To Plan Projects In Carcinogenesis

July 22, 1977

In Brief: NCI Encourages New Grants In For Cancer Sites In Forthcoming PA, Broder Informs Grantees

January 3, 1992

NCI-Approved Trials Listed

April 28, 2006